Theradome PRO LH80
Commercial- Indications
- Androgenetic alopecia, Hair loss
Company intelligence / Profile preview
Theradome’s FDA-cleared wearable laser phototherapy helmets are clinically proven to minimize shedding, thicken existing hair, and promote new hair growth in men and women with androgenetic alopecia. Clinical studies and consumer trials have shown positive results for both efficacy and safety. The devices are used both in clinical settings and at home, with over 100 million treatments performed globally across 57 countries. No major adverse events reported.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Theradome.